

Publisher: John Wiley & Sons Inc
E-ISSN: 1444-0938|98|4|348-352
ISSN: 0816-4622
Source: CLINICAL AND EXPERIMENTAL OPTOMETRY, Vol.98, Iss.4, 2015-07, pp. : 348-352
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


The effects of Valsalva manoeuvre on Ocular Response Analyzer measurements
CLINICAL AND EXPERIMENTAL OPTOMETRY, Vol. 816-4622, Iss. 5, 2015-09 ,pp. :






Oxaliplatin-Related Ocular Toxicity
Case Reports in Oncology, Vol. 3, Iss. 3, 2010-11 ,pp. :